Spreads on CoreWeave’s five-year credit default swaps recently sat between 1,100 and 1,200, past the 1,000 mark the debt market reads as distress.
Now Tuttle Capital Management and Defiance ETFs have filed with the SEC to launch exchange-traded funds that profit when credit default swap spreads widen on CoreWeave, Oracle and the Magnificent Seven — a packaged way to bet against AI debt that, if approved, would be the first of its kind.
The filings land at a moment when the credit market, not the stock market, is doing the loudest talking about the AI buildout. Concerns about balance sheets and valuations in the sector have pressured the market since October, and investors who have shorted publicly traded tech companies in the AI trade have profited.
But debt has been the harder trade to short. These filings aim to solve a specific problem: turn an institutional, over-the-counter instrument into a ticker anyone with a brokerage account can buy.
Three Numbers Before the SEC Rules
- CoreWeave’s 9.75% bond due 2031 yields close to 16%, and its five-year CDS spread sits at 1,100–1,200 — distress territory.
- Oracle’s CDS moved from below 80 to a current range above 300 over the past year.
Shorting Debt, Not Stock
A credit default swap is a contract in which a protection buyer pays periodic premiums to a seller who pays out if the reference borrower suffers a credit event — bankruptcy or failure to pay, under standard terms published by the International Swaps and Derivatives Association.
Wider spreads mean the market sees the bonds as riskier. The proposed ETFs are built to gain when those spreads widen and to lose when the market judges the issuer’s creditworthiness as improving.
According to Tuttle Capital’s prospectus filed with the SEC, the Tuttle Capital ORCL Credit Default Swap ETF would invest at least 80% of its net assets in CDS referencing Oracle’s debt, would hold no Oracle stock or bonds, and would seek leveraged exposure to the widening of Oracle’s credit spread.
Defiance filed a parallel prospectus covering CoreWeave and Oracle among broader AI and semiconductor CDS portfolios. Both managers plan leverage, which raises both risk and the potential for outsized daily moves — the same mechanics as existing single-stock leveraged and inverse ETFs.

The fine print matters. Both prospectuses stress the funds are not designed to move inversely to the reference companies’ stocks and can lose money even while a company’s shares decline. And the funds pay premiums to buy protection — a cost the manager bears whether or not credit conditions ever worsen. That premium drag is the structural difference between this trade and simply shorting the equity.
CoreWeave Is Already Pricing Distress
CoreWeave’s 9.75% bond due in 2031 is yielding close to 16%, and its five-year CDS spread was recently quoted between 1,100 and 1,200 — spreads above 1,000 are generally considered a sign of distress. A bond trading to a 16% yield against a 9.75% coupon tells you the market is pricing that debt well below par.
“I’ve never been more confident in CoreWeave,” Venturo wrote.
Oracle’s Spread More Than Tripled
The spread on a name that anchors billions in AI infrastructure commitments has more than tripled while the equity story stayed intact — which is precisely the divergence a credit-focused fund is designed to monetize.
But the balance sheet tells a different story across the rest of the Magnificent Seven.
Nvidia’s Withdrawal Shadows the Trade
Rowan said neocloud AI projects could face an existential crisis if Nvidia funding dries up.
Hedge Tool or Retail Gamble
Tuttle’s own bar is modest: “My criteria is I want to see a runway to $20 million, which is about our breakeven. I see it here. It doesn’t mean it will happen, but I think we have a decent chance.”
The next gate is the Securities and Exchange Commission, which must approve both filings before a single share trades. Until then, the clearest signal in the AI trade sits where it has sat all year — in the spreads, not the stock prices.
Tuttle Capital Management is led by Matthew Tuttle, who serves as the firm’s Chief Executive Officer and Chief Investment Officer. Tuttle is a familiar presence in financial media, appearing frequently on CNBC and Fox Business and being quoted often in the Wall Street Journal and Barron’s.
He is the author of two books, How Harvard & Yale Beat the Market and Financial Secrets of my Wealthy Grandparents, and holds an MBA in Finance from Boston University. The firm already runs leveraged inverse products, including SKRE, an ETF seeking -200% of the daily performance of the regional banking ETF KRE through total return swaps — the same daily-reset leverage mechanics the new CDS filings describe.
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.